PharmiWeb.com - Global Pharma News & Resources
28-Apr-2023

Asklepios Kliniken: Solid performance in 2022

EQS-News: Asklepios Kliniken / Key word(s): Annual Report
Asklepios Kliniken: Solid performance in 2022
28.04.2023 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

Asklepios Group: Solid performance in 2022

Hamburg, 28 April 2023. 2022 was a challenging financial year for Asklepios Kliniken GmbH & Co. KGaA that was dominated by global political and economic developments.

The Asklepios Group’s healthcare facilities treated around 3.6 million patients in the 2022 financial year, a slight increase on the previous year (2021: 3.5 million).

The Asklepios Group generated revenue of EUR 5.3 billion in the 2022 financial year (previous year: EUR 5.1 billion). Consolidated net operating income (EAT) amounted to EUR 131.9 million (2021: 106.3 million). Capital expenditure totalled EUR 314.0 million in the 2022 financial year (2021: EUR 332.6 million), while the internal financing ratio amounted to 69.5% (2021: 72.8%).

The Asklepios Group enjoyed a stable financial position at the end of the 2022 financial year. The Group’s net debt amounted to EUR 1,376.8 million as at 31 December 2022 (31 December 2021: EUR 1,364.8 million), while cash and cash equivalents amounted to EUR 634.6 million (31 December 2021: EUR 647.2 million). The ratio of net debt to EBITDA for the past 12 months was 3.5x (31 December 2021: 3.6x).

Asklepios will respond flexibly to the expected regulatory requirements in order to mitigate the potential effects on its business activity. Thanks to strategic investments in digitalisation and the shift towards outpatient care, as well as internally financed capital expenditure on its healthcare facilities amounting to EUR 218.3 million, Asklepios has created a sound basis for weathering the challenges well in economic terms. Overall, Asklepios anticipates stable revenue growth and largely positive economic development in 2023.


About Asklepios
Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients, with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has been developing dynamically since it was founded almost 40 years ago. The Group currently has around 170 healthcare facilities throughout Germany. These include acute care hospitals of all different care levels, university hospitals, specialist clinics, psychiatric facilities, forensic institutions, rehabilitation clinics, nursing homes and medical centres. In the 2022 financial year, around 3.6 million patients were treated at the Asklepios Group’s facilities. The company has more than 67,000 employees.

IR contact
Mirjam Constantin
Head of Group Reporting (Financial & ESG)/ Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3 - 61462 Königstein-Falkenstein
Tel.: +49 61 74 90-1166
Fax: +49 61 74 90-1110
ir@asklepios.com

PR contact
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226 - 22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639
presse@asklepios.com

 

Visit Asklepios online, on Facebook or on YouTube:

www.asklepios.com

gesundleben.asklepios.com

www.facebook.com/asklepioskliniken

www.youtube.com/asklepioskliniken



28.04.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Editor Details

Last Updated: 28-Apr-2023